Source: Annual Congress 2005 - CPAP therapy
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
A. L. Andreu, E. Chiner, E. Pastor, E. Gomez-Merino, J. Signes-Costa, M. Llombart, J. M. Arriero, C. Senent, J. Marco (Alicante, Spain). CPAP treatment induces changes in lung diffusion in OSA patients. Eur Respir J 2005; 26: Suppl. 49, 778

Member's Comments

No comment yet.

Related content which might interest you: CPAP increases bronchial reactivity in OSAS patients Source: Eur Respir Rev 2008; 17: 101-102 Year: 2008 CPAP increases bronchial reactivity in OSAS patients Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007 The reversibility of hypoxemia in OSA patients is related to CPAP therapy Source: Eur Respir J 2005; 26: Suppl. 49, 112s Year: 2005 Effects of CPAP treatment in UARS patients comparing to OSAS patients Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007 CPAP appears to protect kidney function of patients with OSA. Source: International Congress 2017 – Central sleep apnoea: consequences and comorbidities of obstructive sleep apnoea Year: 2017 A noninvasive device to measure endothelial dysfunction and its response to CPAP treatment in obstructive sleep apnoea patients Source: Annual Congress 2008 - Diagnostic aspects of sleep apnoea Year: 2008 Effect of continuous positive airway pressure (CPAP) treatment on proangiogenic factors of angiogenesis in obstructive sleep apnea (OSA) patients Source: Eur Respir J 2005; 26: Suppl. 49, 39s Year: 2005 CPAP setting prediction in OSAS patients Source: Annual Congress 2011 - Physiology and diagnostic technology in obstructive sleep apnoea Year: 2011 Effect of continuous positive airway pressure treatment (CPAP) in angiogenic growth factors‘ expression in patients with COPD and obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases Year: 2010 The effect of CPAP treatment on Galectin-3 level in patients with severe obstructive sleep apnea Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing Year: 2018 CPAP vs APAP effects on metabolic and cardiac function in patients with OSAS Source: Eur Respir J 2005; 26: Suppl. 49, 722s Year: 2005 Is the daytime CPAP titration effective for determining therapeutic pressure levels in OSA patients? Source: Eur Respir J 2001; 18: Suppl. 33, 417s Year: 2001 Evaluation of cerebral metabolism after CPAP treatment in OSAS patients Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009 Effect of continuous positive airway pressure on lipid profile in patients with severe OSAS Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing Year: 2018 A study of insulin resistance in moderate to severe obstructive sleep apnea in non diabetics and its response to nasal CPAP treatment Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea Year: 2011 Effect of continuous positive airway pressure treatment on hypoadiponectinemia in male patients with obstructive sleep apnea syndrome Source: Annual Congress 2005 - Metabolic control in OSA Year: 2005 Effects of CPAP treatment on 6MWD in OSAS and overlap syndrome patients Source: Eur Respir J 2002; 20: Suppl. 38, 294s Year: 2002 Why excessive sleepiness may persist in OSA patients receiving adequate CPAP treatment Source: Eur Respir J 2012; 39: 227-228 Year: 2012 Why excessive sleepiness may persist in OSA patients receiving adequate CPAP treatment Source: Eur Respir J 2012; 39: 226-227 Year: 2012 Why excessive sleepiness may persist in OSA patients receiving adequate CPAP treatment Source: Eur Respir J 2011; 39: 227-228 Year: 2012